US2017267632A1PendingUtilityA1

Methionine analogs and methods of using same

57
Assignee: BIOXINESS PHARMACEUTICALS INCPriority: Aug 1, 2008Filed: Jun 1, 2017Published: Sep 21, 2017
Est. expiryAug 1, 2028(~2.1 yrs left)· nominal 20-yr term from priority
C07C 323/60A61P 31/04A61P 31/12C07C 323/66A61P 31/10C07C 259/06A61P 31/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages.

Claims

exact text as granted — not AI-modified
1 - 151 . (canceled) 
     
     
         152 . A method of treating a bacterial infection in an individual comprising administering to the individual an effective amount of a compound of the formula: 
       
         
           
           
               
               
           
         
       
       wherein
 q is 1 or 2; 
 R 8  is hydrogen or C 1 -C 5  alkyl; and 
 C is an optionally substituted L-amino acid residue wherein said substituent is selected from the group consisting of hydroxyl, nitro, amino, cyano, halo, C 1 -C 4  haloalkyl, thiol, C 1 -C 4  thioalkyl, sulfonyl, thioamido, amidino, formyl, C 1 -C 4  alkyl, C 3 -C 9  cycloalkyl, C 1 -C 4  alkoxy, and C 1 -C 4  alkoxy-C 1 -C 4  alkyl; 
 or a pharmaceutically acceptable salt thereof or solvate of the foregoing.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.